Linked Life Data

1107969

Source:http://linkedlifedata.com/resource/pubmed/id/1107969

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Suppl
pubmed:dateCreated
1976-3-30
pubmed:abstractText
The authors present the results of own investigations about the use of both pizotifen (SandomigranR) and cyproheptadine (PeritolR). 32 sufferers were treated with pizotifen and showed positive improvement in 68% of the cases. In this group no serious side effects were found. 20 patients before administration of the drug had placebo and this helped to establish the results statistically. 25 sufferers were treated with cyproheptadine and equally positive results in 64% of the cases. In this group were noted infrequent side effects. The results of the two tests were compared with the results of other tests done with other drug. From this it has been established that the antiserotonin drugs are the most effective at present in the treatment of migraine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0301-0244
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
189-93
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1975
pubmed:articleTitle
Antiserotonin agents in the treatment of migraine.
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial